Effects of chronic treatment with honokiol in spontaneously hypertensive rats

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 3, 2010, Pages 427-431

  Zhang, Gen Shui ^a,b   Wang, Ru Jun ^b   Zhang, Hai Ning ^a   Zhang, Gui Ping ^a   Luo, Miao Shan ^a   Luo, Jian Dong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Aorta; Honokiol; Hypertension; Oxidative stress; Spontaneously hypertensive rat

Indexed keywords

ACETYLCHOLINE; ELASTIN; HONOKIOL; MALONALDEHYDE; NITRATE; NITRITE; NITROPRUSSIDE SODIUM; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; BIPHENYL DERIVATIVE; LIGNAN; NITRIC ACID DERIVATIVE; PLANT EXTRACT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG MEGADOSE; HEART MUSCLE RELAXATION; HISTOLOGY; HYPERTENSION; IN VIVO STUDY; LIVER; LOW DRUG DOSE; NONHUMAN; OXIDATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECTS; MAGNOLIA; METABOLISM; PATHOLOGY;

ACETYLCHOLINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; AORTA; BIPHENYL COMPOUNDS; BLOOD PRESSURE; ELASTIN; HYPERTENSION; LIGNANS; LIVER; MAGNOLIA; MALONDIALDEHYDE; NITRATES; NITRITES; NITROPRUSSIDE; PLANT EXTRACTS; RATS; RATS, INBRED SHR; VASODILATOR AGENTS;

EID: 77649204035     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.427     Document Type: Article

References (26)

1. Fujita M., Itokawa H., Sashida Y., Yakugaku Zasshi, 93, 429-434 (1973).
2. Lin Y. R., Chen H. H., Ko C. H., Chan M. H., Life Sci., 81, 1071-1078 (2007).
3. Lo Y. C., Teng C. M., Chen C. F., Chen C. C., Hong C. Y., Biochem. Pharmacol., 47, 549-553 (1994).
4. Lu Y. C., Chen H. H., Ko C. H., Lin Y. R., Chan M. H., Nauyn-Schmiderberg Arch. Pharmacol., 368, 262-269 (2003).
5. Ko C. H., Chen H. H., Lin Y. R., Chan M. H., Planta Med., 69, 532-636 (2003).
6. Epstein B. J., Vogel K., Palmer B. F., Drugs, 67, 1309-1327 (2007).
7. Touyz R. M., Hypertension, 44, 248-252 (2004).
8. Yuan C., Liang A. J., Zeng L., Jia N., Feng L., Pharm. J. Chin. PLA, 19, 258-262 (2003).
9. Ruan C., Jia N., Zeng L., Zhang L., Geng M., Yuan Z. X., Pharm. Care & Res., 3, 156-159 (2003).
10. Teng C. M., Yu S. M., Chen C. C., Huang Y. L., Huang T. F., Life Sci., 47, 1153-1161 (1990).
11. Lüscher T. F., Vanhoutte P. M., Hypertension, 8, 344-348 (1986).
12. Mulvany M. J., J. Cardiovasc. Pharmacol., 22, S44-S47 (1993).
13. Spieker L. E., Flammer A. J., Lüscher T. F., Handb. Exp. Pharmacol., 176 (Pt 2), 249-283 (2006).
14. Rapoport R. M., Draznin M. B., Murad F., Nature (London), 306, 174-176 (1983).
15. Ignarro L. J., Fukuto J. M., Griscavage J. M., Rogers N. E., Byrns R. E., Proc. Natl. Acad. Sci. U.S.A., 90, 8103-8107 (1993).
16. Rhodes P., Leone A. M., Francis P. L., Struthers A. D., Moncada S., Rhodes P., Biochem. Biophys. Res. Commun., 209, 590-596 (1995).
17. Hwa J. J., Ghibaudi L., Williams P., Chatterjee M., Am. J. Physiol., 266 (3 Pt 2), H952-H958 (1994).
18. Vapaatalo H., Mervaala E., Nurminen M. L., Physiol. Res., 49, 1-10 (2000).
19. Rush J. W., Denniss S. G., Graham D. A., Can. J. Appl. Physiol., 30, 442-474 (2005).
20. Kishi T., Hirooka Y., Kimura Y., Ito K., Shimokawa H., Takeshita A., Circulation, 109, 2357-2362 (2004).
21. Duarte J., Galisteo M., Ocete M.A., Pérez-Vizcaino F., Zarzuelo A., Tamargo J., Mol. Cell. Biochem., 221, 155-160 (2001).
22. Gómez-Amores L., Mate A., Revilla E., Santa-María C., Vázquez C. M., Life Sci., 78, 1945-1952 (2006).
23. Cai H., Harrison D. G., Circ. Res., 87, 840-844 (2000).
24. Levy B. I., Duriez M., Phillipe M., Poitevin P., Michel J. B., Circulation, 90, 3024-3033 (1994).
25. Benetos A., Poitevin P., Prost P. L., Safar M. E., Levy B. I., Am. J. Hypertens., 7, 186-192 (1994).
26. Mohácsi A., Magyar J., Tamás B., Nánási P. P., Curr. Vasc. Pharmacol., 2, 53-63 (2004).